Design
Guideline
Authors
Loading...
May limit routine aPTT/anti-Xa monitoring for heparin; challenges assumptions of reliable assay guidance in guidelines.
Key points are not available for this paper at this time.
M. Greaves (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: